Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TATA Health International Holdings Ltd. ( (HK:1255) ) has provided an update.
TATA Health International Holdings Limited reported its annual financial results for the year ending December 31, 2023. The company experienced a significant increase in revenue from HK$144,606,000 in 2022 to HK$207,542,000 in 2023. Despite the revenue growth, the company faced a loss before taxation of HK$35,420,000, compared to a profit of HK$2,497,000 in the previous year. The gross profit margin decreased from 78.8% to 72.6%, and the loss attributable to owners of the company was HK$32,294,000, down from a profit of HK$8,047,000 in 2022. These results indicate challenges in maintaining profitability despite increased sales, impacting the company’s financial health and stakeholder confidence.
More about TATA Health International Holdings Ltd.
TATA Health International Holdings Limited, incorporated in the Cayman Islands, operates in the health sector. The company is listed on the Hong Kong Stock Exchange and focuses on providing health-related products and services.
Technical Sentiment Signal: Sell
Current Market Cap: HK$72.85M
Learn more about 1255 stock on TipRanks’ Stock Analysis page.